CIBC Asset Management Inc Has $11.43 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

CIBC Asset Management Inc raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 146,218 shares of the company’s stock after buying an additional 5,009 shares during the quarter. CIBC Asset Management Inc’s holdings in GE HealthCare Technologies were worth $11,431,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in GEHC. Blue Trust Inc. lifted its stake in GE HealthCare Technologies by 9.9% in the third quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock valued at $219,000 after buying an additional 210 shares during the period. Raymond James & Associates lifted its stake in GE HealthCare Technologies by 10.4% in the third quarter. Raymond James & Associates now owns 421,356 shares of the company’s stock valued at $39,544,000 after buying an additional 39,654 shares during the period. Resonant Capital Advisors LLC acquired a new position in GE HealthCare Technologies in the third quarter valued at approximately $201,000. Allspring Global Investments Holdings LLC raised its position in shares of GE HealthCare Technologies by 2.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock worth $2,317,000 after purchasing an additional 562 shares during the period. Finally, Koss Olinger Consulting LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth approximately $241,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

GEHC has been the topic of a number of research reports. Citigroup upped their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Trading Up 0.5 %

NASDAQ GEHC opened at $92.67 on Wednesday. The firm has a market capitalization of $42.34 billion, a P/E ratio of 25.46, a PEG ratio of 2.93 and a beta of 1.15. The business has a fifty day simple moving average of $84.45 and a 200 day simple moving average of $85.67. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date was Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.